• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad , Nov. 17

Dr Reddys Laboratories Ltd has announced the pricing of the public offering of 12.5-million (excluding the underwriters over-allotment option) American Depositary Shares (ADS) at $16 per ADS.

In a press release here on Friday, the company said the offering is expected to close on November 22.

At this price, the company would now be in a position to raise funds of $200 million as against the market expectations of around $240 million. The issue size is also one million shares less than what the company proposed earlier.

The company had earlier on November 13 filed a shelf registration statement on Form F-3 and preliminary supplement prospectus with the US Securities and Exchange Commission (SEC) relating to a proposed offering of American Depositary Shares of up to 13.5 million shares, excluding the underwriters' over-allotment option.

The Dr Reddy's scrip suffered a loss of Rs 38 or 5.01 per cent on the Bombay Stock Exchange on Friday. The scrip, which opened at Rs 770, witnessed the day's lowest price of Rs 725.25 and closed at Rs 735.70.

More Stories on : Overseas Borrowings | Stocks | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Merc variant launched in Kerala

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line